NCT06862076

Brief Summary

The aim of this study is to compare the effect of lung function prehabilitation to postoperative pulmonary complications on patient undergoing upper abdominal surgery treated in intensive care unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

March 1, 2025

Last Update Submit

March 5, 2025

Conditions

Keywords

PrehabilitationPostoperative pulmonary complicationsUpper abdominal surgeryIntensive care unit

Outcome Measures

Primary Outcomes (1)

  • Postoperative pulmonary complications

    Including pulmonary infections, atelectasis, and diaphragmatic dysfunction. Pulmonary infection is assessed using the Clinical Pulmonary Infection Score (CPIS) and with a threshold of \>6, atelectasis using Lung Ultrasound Score (LUS) of ≥1, and diaphragm ultrasound were used to evaluate diaphragm ratio. CPIS and LUS score assessments were conducted on postoperative day 1 and 3 by trained investigators, diaphragm ratio assessment was conducted preoperatively and on postoperative day 1 and 3, all findings were systematically recorded.

    Postoperative day 1 and 3

Study Arms (2)

Lung Function Prehabilitation

EXPERIMENTAL

Participants assigned to the prehabilitation group received personalized exercise prescriptions, including aerobic training, muscle strengthening, and inspiratory muscle training with a threshold device. The prehabilitation program was conducted at the participants' homes for a minimum duration of two weeks. Adherence was monitored through logbook entries and video call evaluations to ensure correct implementation of the prescribed exercises.

Procedure: Lung Function Prehabilitation

Standard of Care

NO INTERVENTION

No prehabilitation is done, patients in this group received standard of care.

Interventions

Participants assigned to the prehabilitation group received personalized exercise prescriptions, including aerobic training, muscle strengthening, and inspiratory muscle training with a threshold device. The prehabilitation program was conducted at the participants' homes for a minimum duration of two weeks. Adherence was monitored through logbook entries and video call evaluations to ensure correct implementation of the prescribed exercises.

Lung Function Prehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults 18 years or older
  • scheduled for the upper abdominal surgery under general anesthesia with intraoperative mechanical ventilation
  • possess adequate cognitive function to comprehend and follow instructions
  • possess sufficient physical capacity to perform structured prehabilitation exercises
  • express willingness to participate in the intervention program before surgery

You may not qualify if:

  • pregnancy
  • pre-existing severe pulmonary diseases such as chronic obstructive pulmonary disease (COPD)
  • planned laparoscopic procedures
  • history of significant neuromuscular impairment (e.g: stroke)
  • declined to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RSUPN dr. Cipto Mangunkusumo

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. dr. Dita Aditianingsih, Sp.An-TI., Subsp.T.I.(K).

Study Record Dates

First Submitted

March 1, 2025

First Posted

March 6, 2025

Study Start

August 1, 2023

Primary Completion

June 30, 2024

Study Completion

November 12, 2024

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations